Resolve Biosciences is applying the power of Molecular Cartography™ to enable scientists to gain new insights based on the highest-resolution view of single-cell spatial biology. The platform features the company's proprietary, multiplexed, single-molecule detection technology, which offers full spatial context at subcellular resolution, all in a workflow that preserves the sample tissue. The platform offers unparalleled sensitivity and specificity that helps scientists detect individual transcripts and rare signals to interpret fundamental biology and rapidly advance the understanding of complex biological questions in critical fields such as oncology, neuroscience, and infectious disease. The technology has been under development since 2016 and is currently available through an oversubscribed early access program.
Externer Link zu Resolve BioSciences
Alfred-Nobel Straße 10
Gebäude 03
Monheim am Rhein, Nordrhein-Westfalen 40789, DE
Resolve BioSciences hat dies direkt geteilt
I am delighted to announce that I will be speaking at the 10th Anniversary of the Innate Killer Summit. Back to celebrate a decade of uniting the NK community, join us in March to pave the way to revolutionary allogeneic and innate immunity treatment. Access my talk here: https://ter.li/j0zipr
Resolve BioSciences hat dies direkt geteilt
Check out this comprehensive guide to single-cell analysis covering the best practices from unimodal to multimodal single-cell data. Whether you're new to the field or an experienced researcher, this is a valuable resource to explore different tools and curated recommendations from the scientific community. https://lnkd.in/ge5tkcwR #singlecell #lifesciences #genomics
Check out this comprehensive guide to single-cell analysis covering the best practices from unimodal to multimodal single-cell data. Whether you're new to the field or an experienced researcher, this is a valuable resource to explore different tools and curated recommendations from the scientific community. https://lnkd.in/ge5tkcwR #singlecell #lifesciences #genomics
Resolve BioSciences hat dies direkt geteilt
A huge day for spatial omics of cancer, tracing the precise origin and evolution of 20 types of cancer, many in 3D, in ~2,000 individuals, with 12 publications Collection: https://lnkd.in/gimEh9PK
'A spatially resolved single-cell genomic atlas of the adult human breast' was published in Nature last year by a team of researchers at the MD Anderson Cancer Center. Utilizing our Molecular Cartography platform and other technologies, they constructed the comprehensive Human Breast Cell Atlas at single-cell and spatial resolution, in which they profiled over 700,000 cells. This data provides a reference of the breast tissue for studying mammary biology and diseases such as breast cancer. Read more here: https://lnkd.in/eD-y8SCB #breastcancerawarenessmonth #breastcancer #cancerresearch
Ever wondered how the shape and structure of tissues impact cell development? MRC researchers discovered critical insights using human brain organoids as a tracking model. Utilizing the Molecular Cartography platform, they found that developing brain cells need the right spatial coordinates to follow the correct timeline of development. Check out the #CellPress publication here: https://lnkd.in/enH5XKe8 #neurosciences #neurology #genomics
October is #BreastCancerAwarenessMonth. Did you know that each year breast cancer accounts for 30% of all new cancer cases in women in the United States? In fact, 13% of women will develop invasive breast cancer in their lifetime. Currently, there are over 4 million breast cancer survivors in the US. With constant research and treatment advancements being made, it is critical to invest in technology aimed at developing targeted treatments and precision immuno-oncology drugs for breast cancer patients. Statistics from breastcancer.org. Graphic from National Breast Cancer Foundation, Inc. #immunotherapy #breastcancer #resources
Single-cell multi-omics offers the promise of understanding cellular heterogeneity and complex processes, such as tumor progression. However, current studies rely on non-parallel methods that integrate modalities from different datasets (like transcriptomic and proteomics), muddling our view of cell types or states. Access to parallel methods measuring multi-omics modalities on the same cells is limited, with drawbacks like low throughput and lack of automation. We anticipate significant progress in this field. What are your thoughts on these multi-omics challenges? And how should the field address them? https://lnkd.in/gigsZNN6 #bioinformatics #lifescience #genomics #Nature
Are you exploring opportunities in spatial biology and pathology? We’re seeking talented professionals in the US, Germany, and the Netherlands to join our teams across several departments, including many new and exciting openings on our Commercial team. If you or someone in your network is ready to take the next step in life sciences, check out our open positions at the link below. 🧬 https://lnkd.in/gTECgyNN #lifesciences #biotech #biotechjobs #NLDjobs #USAjobs #DEUjobs
September is Blood Cancer Awareness Month. Currently, nearly 1.7 million people in the United States are living with or in remission from blood cancers such as leukemia and lymphoma. This year alone, experts expect over 62,000 new cases in the US. Organizations like the American Association for Cancer Research are at the forefront of supporting research investigating these cancers, helping improve treatments, and bringing hope to patients and families affected by these diseases. Learn more at the link: https://lnkd.in/eisxTcjT #AACR #September #BloodCancerAwarenessMonth #cancerresearch